Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 29Terminated 9Withdrawn 4Unknown 2Active not recruiting 1

Sponsor Class

NIH 60OTHER 28UNKNOWN 3OTHER_GOV 2NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 1CNS 1

Conditions

Meningioma 1Melanoma 1Central Nervous System Neoplasms 1

Interventions

Cisplatin 15Paclitaxel 14Taxes 10Cyclophosphamide 9Carboplatin 9Gemcitabine 7Platinum 61,2-diaminocyclohexaneplatinum II citrate 6Trastuzumab 5Radiotherapy 5Oxaliplatin 5Doxorubicin 5Docetaxel 5Cytarabine 5Capecitabine 5Brachytherapy 5fludarabine 4Rituximab 4Radiotherapy, Intensity-Modulated 4Radiosurgery 4Fluorouracil 4Dexamethasone 4Watchful Waiting 3Radiotherapy, Conformal 3Pemetrexed 3Nimorazole 3Lenalidomide 3Imatinib Mesylate 3Idarubicin 3Gene Expression Profiling 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × NETWORK × Chemotherapy, Adjuvant × Clear all
NCT00626730 2021-02-03

Radiation Therapy in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Grade II or Grade III Meningioma

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Unknown
78 enrolled
CNS

Meningioma, Central Nervous System Neoplasms

NCT00006249 2015-02-10

Interferon Alfa Following Surgery in Treating Patients With Stage III Melanoma

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Unknown
1,258 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡